NG RAYMOND
No ORCID on file
· 70 papers in corpus
· active 2003-2008
Frequent coauthors
- JAIN Nareshkumar F. 70
- KANOJIA Ramesh M. 70
- SUI ZHIHUA 70
- XU JIAYI 70
2008
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2008
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2008
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2008
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2008
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2008
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2008
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2008
Disclosed are heteroatom containing tetracyclic derivatives. The compounds are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosi…
2008
Disclosed are heteroatom containing tetracyclic derivatives. The compounds are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosi…
2008
Disclosed are heteroatom containing tetracyclic derivatives. The compounds are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosi…
2008
Disclosed are heteroatom containing tetracyclic derivatives. The compounds are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosi…
2008
Disclosed are heteroatom containing tetracyclic derivatives. The compounds are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosi…
2008
Disclosed are heteroatom containing tetracyclic derivatives. The compounds are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosi…
2008
Disclosed are heteroatom containing tetracyclic derivatives. The compounds are useful in the treatment and/or prevention of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosi…
2007
The disclosure is directed to heteroatom containing tetracyclic derivatives of formula (I), wherein the variables are as defined in the specification, pharmaceutical compositions containing them, their use in the treatment and/or prevention…
2007
The disclosure is directed to heteroatom containing tetracyclic derivatives of formula (I), wherein the variables are as defined in the specification, pharmaceutical compositions containing them, their use in the treatment and/or prevention…
2007
The disclosure is directed to heteroatom containing tetracyclic derivatives of formula (I), wherein the variables are as defined in the specification, pharmaceutical compositions containing them, their use in the treatment and/or prevention…
2007
The disclosure is directed to heteroatom containing tetracyclic derivatives of formula (I), wherein the variables are as defined in the specification, pharmaceutical compositions containing them, their use in the treatment and/or prevention…
2007
The disclosure is directed to heteroatom containing tetracyclic derivatives of formula (I), wherein the variables are as defined in the specification, pharmaceutical compositions containing them, their use in the treatment and/or prevention…
2007
The disclosure is directed to heteroatom containing tetracyclic derivatives of formula (I), wherein the variables are as defined in the specification, pharmaceutical compositions containing them, their use in the treatment and/or prevention…
2007
The disclosure is directed to heteroatom containing tetracyclic derivatives of formula (I), wherein the variables are as defined in the specification, pharmaceutical compositions containing them, their use in the treatment and/or prevention…
2006
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2006
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2006
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …
2006
The present invention is directed to novel heteroatom containing tetracyclic derivatives, pharmaceutical compositions containing them, their use in the treatment and/or prevention of disorders mediated by one or more estrogen receptors and …